Emergency Department Visits for Serious Diagnoses During the COVID-19 Pandemic
Emergency Department Visits for Serious Diagnoses During the COVID-19 Pandemic
复制标题
DOI:
10.1111/acem.14099
复制
发表时间:
2020-08-17
影响因子:
4.4
通讯作者:
McCarthy, Danielle M.
中科院分区:
文献类型:
--
作者:
Kim, Howard S.;Cruz, Daniel S.;McCarthy, Danielle M.
The coronavirus disease 2019 (COVID-19) pan-demic has significantly affected health care utilization in the United States. Although reductions in routine outpatient visits and elective procedures were intentional in preparation for increases in COVID-19–related volume, 1 National Syndromic Surveillance Program data indicate that weekly emergency department (ED) visits decreased 42% during the early stages of the pandemic. 2 This reduction may have been driven by a public fear of seeking care, 3, 4 ultimately delaying interventions for time-sensitive serious conditions. A group of US hospitals recently reported a 38% reduction in ST-elevation myocardial infarction (STEMI) activations, 5 and a national neuroimaging database indicated a 39% reduction in patients undergoing stroke imaging. 6 To yield a more complete picture of the COVID-19 pandemic’s effect on emergency care, we sought to describe ED visit trends for other serious diagnoses requiring acute intervention or hospitalization. We conducted a cross-sectional study of adult visits to seven EDs in a large health system located in greater Chicago, Illinois, with a combined 2019 visit volume of 308,000. These seven EDs include one urban academic hospital, five suburban community hospitals, and one free-standing ED. Additional hospital characteristics are included in Data Supplement S1, Appendix S1 (, available as supporting information in the online version of this paper, which is available at http://onlinelibrary. wile y. com/doi/10.1111/acem. 14099/full) We measured ED visit frequencies for serious diagnoses during the early stages of the COVID-19 pandemic (March 8 to May 2, 2020), a period of time encompassing the World Health Organization pandemic declaration on March 11, 2020, up to the date of data collection. We then compared this early pandemic period to a prepandemic period (December 31, 2019, to March 7, 2020) and a historical control period from the prior year (March 10, 2019, to April 27, 2019). Thus, the total study duration spanned from March 10, 2019, to May 2, 2020. This study was approved by the Northwestern University Institutional Review Board. We selected a limited set of serious diagnoses associated with the need for emergency care by multiple rounds of consensus-driven discussion. This process was guided by the priority selection of conditions requiring time-sensitive intervention (eg, acute myocardial infarction) or the need for timely therapy to prevent clinical deterioration (eg, gastrointestinal hemorrhage). We were additionally guided by the need to limit the overall number of diagnoses to preserve meaningful data visualization and to minimize the risk of achieving statistical significance through multiple comparisons alone. We did not include symptom-based diagnoses (eg, chest pain) given that these are nonspecific by definition.